Skip to content
  • Chief Executives for Corporate Purpose ®

    CECP is the only business counsel and network dedicated to driving measurable returns on purpose.

  • Investing in Society: 2024 Edition

    Out NOW! Download this year's report, the must-read source for trends on the corporate sector’s shift to be increasingly purpose-driven.

  • CECP Summit: Purpose + Persistence

    The 2025 Charlie Award application is now open!

What We Do

CECP is the only business counsel and network dedicated to driving measurable returns on purpose.
Our Services
  • Research

    Industry-leading research and actionable insights to transform companies’ corporate purpose work. Annual publications include Giving in Numbers, Global Impact at Scale, and Investing in Society

  • Benchmarking

    Drawing from its 20+ year Giving in Numbers data set, CECP delivers customized benchmarking and in-depth analysis on corporate societal investments.

  • Strategy

    Offering deeper dives via Accelerators, Advanced Advisories, and Fast Track Consulting to meet companies where they are and get them where they want to be.

  • Communications

    Tapping long-standing relationships with media to weave case studies of purpose into trends, topics, and advice.

  • Convening

    Engaging corporate leaders and CEOs in deep conversation to build a better world through business.

Our CEO Coalition, In Numbers

$23B

social
investment

22.5M

hours of employee engagement

$7.7T

total revenue

200+

companies

$21T

assets under management of the CEO Investor Forum

In Logos

Testimonials

CECP’s Board of Boards serves as an excellent forum for sharing insights with top business leaders who are genuinely committed to tackling some of society’s most challenging problems.
Our companies depend upon, and contribute to, the social and economic well-being of the customers and communities we serve, and the opportunity to focus on that reality with like-minded individuals is highly rewarding and productive.

Ken Frazier

Executive Chairman and Former CEO, Merck